StockData
GENELUX Corp logo

GENELUX Corp (GNLX) stock

GNLXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 13, 2026Score 5/30
$2.00+0.08 (+4.17%)

Close on Nov 17, 2026Market cap $90.49MP/E –Yield –

Genelux enterprise value

Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.

Genelux's enterprise value was $66.11M on Nov 11, 2026, against $190.63M a year earlier. Over the last 4 years it ranged from $33.02M to $793.95M, with a median of $105.66M.

Enterprise Value at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$66.11M-54.4%
2025Dec 31, 2025$144.97M+212.1%
2024Dec 31, 2024$46.45M-86.5%
2023Dec 29, 2023$344.51M–

More Genelux figures

See a number that looks wrong?